Summary
Participation and inclusion in biomedical research remain disproportionate across sociodemographics limiting discoveries in genomic studies and contributing to systemic disparities in healthcare. To alleviate such inequities, the National Institute of Health initiated the All of Us Research Program (AoU), a prospective, population-based cohort to identify the root causes and consequences of health outcomes across diverse demographics. We quantify representation of key racial groups in the accruing AoU cohort of US adults aged ≥18 years and compare to their actual representation in the US. Of the 358,705 AoU participants to date, Hispanic or Latino participants were underrepresented by 0.85-fold, non-Hispanic Asian by 0.58-fold, non-Hispanic White by 0.98-fold, and Other by 0.43-fold. Meanwhile, individuals identifying as non-Hispanic Black or African American were overrepresented by 1.88-fold. While AoU representation better mirrors the US demographics compared to other cohorts, recruitment trends for the ongoing AoU underscore the need to further tailor participation initiatives for diverse populations.
Competing Interest Statement
Dr. Bhattacharya is a medical consultant to Casana Care Inc, unrelated to present work. Dr. Natarajan reports personal consulting fees from Allelica, Amgen, Apple, AstraZeneca, Blackstone Life Sciences, Foresite Labs, Genentech/Roche, Novartis, and TenSixteen Bio, investigator-initiated grants from Apple, AstraZeneca, Amgen, Novartis, and Boston Scientific, is a co-founder of TenSixteen Bio, is a scientific advisory board member of Esperion Therapeutics, TenSixteen Bio, and geneXwell, and spousal employment at Vertex, all unrelated to the present work.
Funding Statement
Dr. Cho is supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant no.: HI19C1330). Dr. Bhattacharya is supported by the John S. LaDue Memorial Fellowship in Cardiovascular Research. Dr. Natarajan is supported by a grant from the National Human Genetics Research Institute (U01HG011719) and Massachusetts General Hospital (Paul and Phyllis Fireman Endowed Chair in Vascular Medicine). The funders/sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Massachusetts General Hospital institutional review board approved the secondary use of the ACS 2020 (2021P002212) and AoU Research Program data (2020P001737). Informed consent for American Community Survey (ACS) was waived because it is routinely collected and deidentified data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
American Community Survey 2020 aggregate data are publicly available at https://www.census.gov/programs-surveys/acs and All of Us controlled access individual-level data are available at https://allofus.nih.gov. All original code and any additional information required to reanalyze the data reported in this paper are available from the lead contact upon reasonable request.